Undervalued Stocks Based On Cash Flows

Results

144

28 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

144 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
SPT
New
US$9.55-5.0%-36.2%US$599.3mUS$10.441.2107.1%n/aSoftware
HBT
US$36.942.8%47.1%US$1.4bUS$40.401.828.5%2.7%Banks
GLOO
US$3.20-8.0%n/aUS$285.7mUS$12.332.1105.5%n/aSoftware
HAE
New
US$90.274.2%69.9%US$4.1bUS$96.9042.723.5%n/aHealthcare
CPRI
US$14.67-4.9%-28.4%US$1.7bUS$22.5318.124.4%n/aConsumer Durables
OCFC
New
US$19.643.4%14.5%US$1.9bUS$22.080.865.1%4.1%Banks
MELI
US$1,787.57-2.0%-24.4%US$93.5bUS$2,256.5448.629.0%0%Retail
LUV
US$43.35-3.5%38.5%US$21.7bUS$51.7925.321.7%1.7%Transportation
NTRA
New
US$314.18-1.3%95.0%US$44.7bUS$330.6416.762.7%n/aPharmaceuticals & Biotech
TE
New
US$4.88-8.1%214.8%US$1.5bUS$9.861.498.9%n/aSemiconductors
J
US$143.63-2.5%-2.2%US$16.9bUS$162.5346.828.7%1.0%Commercial Services
LITE
New
US$968.9019.1%714.3%US$82.1bUS$1,148.3028.5104.4%n/aTech
XERS
New
US$8.526.6%15.8%US$1.6bUS$11.294.655.9%n/aPharmaceuticals & Biotech
AEIS
New
US$348.6310.9%127.5%US$13.2bUS$429.0863.343.1%0.1%Tech
WLTH
US$9.16-3.7%n/aUS$1.4bUS$12.253.785.4%n/aDiversified Financials
ALRS
US$33.490.8%55.3%US$838.5mUS$35.4030.340.6%2.6%Diversified Financials
RHI
US$42.47-0.5%18.6%US$4.3bUS$35.0037.231.8%5.6%Commercial Services
SYM
US$42.706.5%-16.4%US$25.8bUS$64.32675.655.5%n/aCapital Goods
HBAN
US$17.952.0%7.6%US$36.2bUS$20.301.225.7%3.5%Banks
TYGO
New
US$1.17-0.8%-10.0%US$93.7mUS$2.839.023.1%n/aCapital Goods
GPC
US$132.52-1.5%-3.4%US$18.6bUS$140.38557.641.7%3.2%Retail
YOU
US$43.84-14.4%30.9%US$6.1bUS$62.6030.522.0%1.8%Software
VSXY
US$84.10-15.9%270.2%US$7.1bUS$92.6031.746.0%n/aRetail
ZETA
US$28.834.7%46.3%US$7.3bUS$31.004.649.1%n/aSoftware
Page 1 of 4